Debt decreased 100.0%
Debt changed -100.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt changed -100.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -19.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +1106 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed -75.8% from the comparable as-filed period.
Operating margin changed +504 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +30.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +131.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed +186.3% from the comparable as-filed period.
Gross profit changed +43.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed +36.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed +360 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +72.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed +160 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +29 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +7.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.